-
Andalus, a compound preparation for adult type 2 diabetes, is listed in China
AstraZeneca has recently announced the release of Andaishi& Reg; (Common name: Daggligin Metformin Sustained Release Tablets) This compound preparation for type 2 diabetes is marketed in China. It is ... -
Lilly is reported to have reached a cooperation agreement with two pharmaceutical companies regarding the filling of injection pens
Lilly has reached a cooperation agreement with two pharmaceutical companies regarding the filling of injection pens. Lilly has reached an agreement with National Resilience in the United States and B ... -
Novo Nordisk invests approximately 4 billion RMB in the expansion project of sterile preparations in Tianjin
Novo Nordisk has invested approximately 4 billion RMB in the expansion project of sterile preparations in Tianjin. The entire project is planned to be completed by 2027. Previously, in the first quar ... -
Novo Nordisk invests approximately 4 billion RMB in the expansion project of sterile preparations in Tianjin
According to AI News, on March 19th, according to the official WeChat account of Novo Nordisk China, Novo Nordisk announced an investment of approximately 4 billion RMB in Tianjin for the expansion p ... -
Novo Nordisk invests approximately 4 billion RMB in the expansion project of sterile preparations in Tianjin
Novo Nordisk has announced an investment of approximately 4 billion RMB in Tianjin for the expansion project of sterile preparations, with the entire project planned to be completed by 2027. Previous ... -
Novo Nordisk invests approximately 4 billion RMB in the expansion project of sterile preparations in Tianjin
On March 19th, Southern Finance and Economics reported that Novo Nordisk announced on its official WeChat account that it will invest approximately 4 billion yuan in a sterile formulation expansion p ... -
Novo Nordisk invests approximately 4 billion yuan in the expansion project of sterile preparations in Tianjin
According to Novo Nordisk's official WeChat account on March 19th, Novo Nordisk announced an investment of approximately 4 billion yuan in Tianjin for the expansion project of sterile preparations, w ... -
4 billion yuan! Novo Nordisk launches aseptic formulation expansion project
On March 19th, Novo Nordisk announced an investment of approximately 4 billion yuan in Tianjin for the expansion project of sterile preparations, and held the groundbreaking ceremony for the expansio ... -
The world's first weekly insulin preparation has encountered setbacks in the United States, and the FDA requires additional information, with no hope of approval this year
The world's first weekly insulin preparation has encountered setbacks in its launch in the United States. On July 10, Denmark time, Novo Nordisk announced that it had received a complete response let ...